Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sparano

Showing results (101-110 of 293) with videos related to

Pageof 30
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancerJ A Sparano, J Speyer, W J Gradishar, et al.
Cancer|September 24, 2010
Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myelomaRuben Niesvizky, Scott Ely, Tomer Mark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbationJ A Sparano, S Wadler, R B Diasio, et al.
Breast Cancer Research and Treatment|July 24, 2013
Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathyLinda T Vahdat, Agustin A Garcia, Charles Vogel, et al.
Frontiers in Oncology|July 28, 2020
The Contribution of Race to Breast Tumor Microenvironment Composition and Disease ProgressionGina Kim, Jessica M Pastoriza, John S Condeelis, et al.
American Journal of Clinical Oncology|August 7, 2003
Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphomaHuda Salman, Alejandra Perez, Joseph A Sparano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of lifeAlyson B Moadel, Chirag Shah, Judith Wylie-Rosett, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 4, 2006
Severe amnesia following bilateral medial temporal lobe damage occurring on two distinct occasionsG Di Gennaro, L G Grammaldo, P P Quarato, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2008
Effect of antacid on imatinib absorptionBrian A Sparano, Merrill J Egorin, Robert A Parise, et al.
The American Journal of Pathology|May 26, 2006
Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive statusTianhong Li, Federica Sotgia, Magalis A Vuolo, et al.
Pageof 30

Showing results (101-110 of 293) with videos related to

Sort By:
Pageof 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancerJ A Sparano, J Speyer, W J Gradishar, et al.
Cancer|September 24, 2010
Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myelomaRuben Niesvizky, Scott Ely, Tomer Mark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbationJ A Sparano, S Wadler, R B Diasio, et al.
Breast Cancer Research and Treatment|July 24, 2013
Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathyLinda T Vahdat, Agustin A Garcia, Charles Vogel, et al.
Frontiers in Oncology|July 28, 2020
The Contribution of Race to Breast Tumor Microenvironment Composition and Disease ProgressionGina Kim, Jessica M Pastoriza, John S Condeelis, et al.
American Journal of Clinical Oncology|August 7, 2003
Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphomaHuda Salman, Alejandra Perez, Joseph A Sparano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of lifeAlyson B Moadel, Chirag Shah, Judith Wylie-Rosett, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 4, 2006
Severe amnesia following bilateral medial temporal lobe damage occurring on two distinct occasionsG Di Gennaro, L G Grammaldo, P P Quarato, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2008
Effect of antacid on imatinib absorptionBrian A Sparano, Merrill J Egorin, Robert A Parise, et al.
The American Journal of Pathology|May 26, 2006
Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive statusTianhong Li, Federica Sotgia, Magalis A Vuolo, et al.
Pageof 30